Postmortem brain study reveals altered endocannabinoid gene expression in people with alcohol use disorder
Brain tissue from people with alcohol use disorder showed dramatically altered endocannabinoid system gene expression, with CB1 receptor genes elevated up to 125% and CB2 receptor genes reduced by half.
Quick Facts
What This Study Found
Individuals with AUD showed higher CNR1 expression in the prefrontal cortex (+125%) and nucleus accumbens (+78%), lower CNR2 expression in both regions (-50% and -49%), and region-specific differences in GPR55, FAAH, and MGLL expression.
Key Numbers
CNR1: +125% in PFC, +78% in NAc. CNR2: -50% in PFC, -49% in NAc. GPR55: +19% in PFC, -51% in NAc. FAAH: -15% in PFC, +24% in NAc. MGLL: no change in PFC, -15% in NAc.
How They Did This
Postmortem case-control study comparing endocannabinoid system gene expression via qPCR in prefrontal cortex and nucleus accumbens tissue from 18 AUD patients (mean 35.5 drinking years) and 18 age-matched controls.
Why This Research Matters
These findings provide direct human brain evidence that chronic alcohol use is associated with widespread changes in the endocannabinoid system, suggesting this system may be a therapeutic target for alcohol addiction.
The Bigger Picture
Most endocannabinoid-addiction research relies on animal models. This postmortem study provides rare direct evidence from human brains, confirming that ECS changes translate to the human condition.
What This Study Doesn't Tell Us
Small sample size (18 per group). Postmortem tissue cannot establish causation. Gene expression does not necessarily reflect protein levels or functional activity. Exploratory and not pre-registered.
Questions This Raises
- ?Would medications that normalize CB1/CB2 balance reduce alcohol craving or consumption?
- ?Do these ECS alterations reverse with sustained abstinence?
Trust & Context
- Key Stat:
- higher CB1 receptor gene expression in prefrontal cortex of individuals with alcohol use disorder vs. controls
- Evidence Grade:
- Postmortem human brain tissue provides valuable direct evidence, but the small sample, exploratory design, and inability to determine causation limit conclusions.
- Study Age:
- 2025 publication.
- Original Title:
- Endocannabinoid system gene expression in mesocorticolimbic brain regions of individuals with alcohol use disorder: A descriptive study.
- Published In:
- Addiction (Abingdon, England) (2025)
- Authors:
- García-Gutiérrez, María Salud(3), Torregrosa, Abraham Bailén, Navarrete, Francisco(9), Aracil-Fernández, Auxiliadora, Rubio, Gabriel, Manzanares, Jorge
- Database ID:
- RTHC-06506
Evidence Hierarchy
Compares people with a condition to similar people without it.
What do these levels mean? →Frequently Asked Questions
Why study postmortem brains?
Gene expression in deep brain structures like the nucleus accumbens cannot be measured in living humans. Postmortem tissue from brain banks provides the only direct way to examine molecular changes in these regions.
What do the CB1 and CB2 changes mean?
CB1 receptors are involved in reward and motivation, while CB2 receptors modulate inflammation and immune responses. The simultaneous upregulation of CB1 and downregulation of CB2 suggests chronic alcohol use creates an imbalance that may sustain addictive behavior and neuroinflammation.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-06506APA
García-Gutiérrez, María Salud; Torregrosa, Abraham Bailén; Navarrete, Francisco; Aracil-Fernández, Auxiliadora; Rubio, Gabriel; Manzanares, Jorge. (2025). Endocannabinoid system gene expression in mesocorticolimbic brain regions of individuals with alcohol use disorder: A descriptive study.. Addiction (Abingdon, England). https://doi.org/10.1111/add.70293
MLA
García-Gutiérrez, María Salud, et al. "Endocannabinoid system gene expression in mesocorticolimbic brain regions of individuals with alcohol use disorder: A descriptive study.." Addiction (Abingdon, 2025. https://doi.org/10.1111/add.70293
RethinkTHC
RethinkTHC Research Database. "Endocannabinoid system gene expression in mesocorticolimbic ..." RTHC-06506. Retrieved from https://rethinkthc.com/research/garcia-gutierrez-2025-endocannabinoid-system-gene-expression
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.